2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Other free copies

• pure.amsterdamumc.nlPublished version · Web page
• University of Geneva (archive-ouverte.unige.ch)Published version · Web page
• Royal Netherlands Academy of Arts and Sciences (pure.amc.nl)Preprint · Web page
• Royal Netherlands Academy of Arts and Sciences (academic.oup.com)Preprint · Web page
• University of Milan (hdl.handle.net)Preprint · Web page
• ibn.idsi.mdPreprint · Web page
• ibn.idsi.mdPreprint · Web page
• Cyprus University of Technology (api.elsevier.com)Preprint · Web page
• Queen's University Belfast (pure.qub.ac.uk)Preprint · Web page
• Leiden University (hdl.handle.net)Preprint · Web page

Abstract

The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.The ESC and EAS is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC/EAS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC/EAS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC/EAS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC/EAS Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.